bharat-biotech
bharat biotech
Bharat Biotech Likely to Increase Covaxin Production to 12 Million Doses Per Month by July: Report
COVAX Expects to Deliver Covid-19 Vaccine Doses to Nations Despite Reduced Supply Availability: WHO
Covid-19: Govt's Expert Panel Allows Clinical Trials for Third Dose of Covaxin
Bharat Biotech, Biovet, and Sapigen Partners with CSIR-IICT to Develop Indigenous Vaccines
SC Stays Hearings in HCs on Covid Vaccines, Issues Notices on Pleas of Manufacturers
Ocugen Plans to Sell 100 Million Doses of Bharat Biotech's Covaxin in US in 2021: Report
Covid-19 Vaccination Based on Vulnerability of Citizens to Infection, Not Profession Wise: Delhi HC Told
Bharat Biotech's Covaxin Safe But Need Phase 3 Results to Assess Effectiveness, Says Lancet
Covaxin Efficacy Yet to be Reviewed by Govt, Bharat Biotech to Submit Data in 2-3 Days: Report
54% of Hyderabad's Population Estimated to Have Antibodies Against Covid-19, Says Study
HC Asks Serum Institute, Bharat Biotech to Disclose Capacity to Manufacture Covid-19 Vaccines
Decision to Use Covaxin was Scientific, Say Govt Sources After it Shows 81% Efficacy as India Wins Global Applause
Bharat Biotech's Covaxin Has 81% Efficacy. Here's How it Compares to Serum Institute's Covishield
81% Interim Efficacy Data Shot in the Arm for Bharat Biotech's Covaxin Export Hopes
Covaxin Shows Interim Efficacy of 81% in Phase 3 Results, Announces Bharat Biotech
Beijing Dismisses Alleged Chinese Hacking of Bharat Biotech, Serum Institute of India
India's Covid-19 Vaccine Innovation And Development Strategy Wins WHO Praise
After Power Grid, China Hackers Also Targeted Indian Vaccine Makers for 'Competitive Advantage': Report
Bharat Biotech to Supply 20 Million Doses of Covaxin to Brazil
Drugs Controller Rejects Bharat Biotech's Request for Covid Vaccine Trials on Kids, Seeks Efficacy Data First
